Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Gynecology

Therapeutic area intelligence for Gynecology with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
7
Catalysts
0
Companies
1

Companies

Bayer →

Assets

Mirena →
NINDS →
Taohe →

Recent signals(7)

ClinicalJuly 31, 2026

Study on Intrauterine Stent Placement to Prevent Adhesions Post-Surgery

The study investigates the efficacy of an intrauterine foley catheter balloon in preventing internal scar tissue after hysteroscopic septum resection.

ClinicalJuly 25, 2026

Taohe Chengqi Decoction Shows Potential in Treating Acute Pelvic Inflammatory Disease

Taohe Chengqi Decoction ameliorates inflammatory injury in a model of acute pelvic inflammatory disease.

ClinicalJuly 16, 2026

Bayer's Mirena Investigated for Nonatypical Endometrial Hyperplasia Treatment

A clinical trial is underway to evaluate the efficacy and safety of Mirena for treating nonatypical endometrial hyperplasia.

ClinicalJuly 14, 2026

Study on SuJok Therapy for Primary Dysmenorrhea Shows Potential Benefits

A clinical trial is investigating the effects of SuJok therapy on dysmenorrhea and quality of life in young women.

ClinicalJune 29, 2026

Study Compares vNOTES and Laparoscopy on Respiratory and Hemodynamic Outcomes

A study is underway to compare respiratory mechanics and hemodynamics between vNOTES and laparoscopic surgery.

ClinicalJune 25, 2026

Study on Pelvic Pain in Women with Endometriosis to Explore Treatment Approaches

A study sponsored by NINDS is investigating pelvic pain in women with endometriosis, focusing on hormonal and genetic factors.

ClinicalJune 22, 2026

Study on ICG for Enhanced Visualization of Ureters in Deep Infiltrating Endometriosis

A clinical trial is investigating the use of ICG for improved visualization of ureters during laparoscopic surgery in patients with deep infiltrating endometriosis.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Inflammatory Disease →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.